Wenfeng Xu

8.5k total citations · 3 hit papers
43 papers, 3.8k citations indexed

About

Wenfeng Xu is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Wenfeng Xu has authored 43 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Wenfeng Xu's work include Plant-Microbe Interactions and Immunity (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Genomics and Phylogenetic Studies (5 papers). Wenfeng Xu is often cited by papers focused on Plant-Microbe Interactions and Immunity (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Genomics and Phylogenetic Studies (5 papers). Wenfeng Xu collaborates with scholars based in China, United States and United Kingdom. Wenfeng Xu's co-authors include Earl W. Davie, Henrik Andersen, Donald C. Foster, Theodore E. Whitmore, Teresa Gilbert, Scott Presnell, Andrew Ching, David P. Yee, Harald S. Haugen and Julia Parrish-Novak and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Wenfeng Xu

41 papers receiving 3.7k citations

Hit Papers

TACI and BCMA are receptors for a TNF homologue implicate... 1998 2026 2007 2016 2000 1998 2009 250 500 750

Peers

Wenfeng Xu
Joseph R. Slupsky United Kingdom
R. Kato United States
Seth J. Corey United States
William F. C. Rigby United States
C L Verweij Netherlands
Emmanuel Zorn United States
Joseph R. Slupsky United Kingdom
Wenfeng Xu
Citations per year, relative to Wenfeng Xu Wenfeng Xu (= 1×) peers Joseph R. Slupsky

Countries citing papers authored by Wenfeng Xu

Since Specialization
Citations

This map shows the geographic impact of Wenfeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenfeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenfeng Xu more than expected).

Fields of papers citing papers by Wenfeng Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenfeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenfeng Xu. The network helps show where Wenfeng Xu may publish in the future.

Co-authorship network of co-authors of Wenfeng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenfeng Xu. A scholar is included among the top collaborators of Wenfeng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenfeng Xu. Wenfeng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yipeng, Ting Chen, Wenfeng Xu, et al.. (2025). Characterization of a rapid 17β-estradiol-degrading strain, Microbacterium proteolyticum ZJSU01. Applied Microbiology and Biotechnology. 109(1). 112–112.
2.
Liu, Tao, et al.. (2024). A multi-omics study reveals the therapeutic effect of Linderae Radix water extract on irritable bowel syndrome (IBS-D). Journal of Ethnopharmacology. 328. 118050–118050. 4 indexed citations
3.
Xu, Wenfeng, et al.. (2023). Epithelioid Subtype Gastrointestinal Stromal Tumors of Stomach in an Endoscopic Biopsy: A Potential Diagnostic Pitfall. OncoTargets and Therapy. Volume 16. 1043–1049.
4.
Wang, Mei, et al.. (2021). The Cardiorespiratory fitness of children and adolescents in Tibet at altitudes over 3,500 meters. PLoS ONE. 16(8). e0256258–e0256258. 12 indexed citations
5.
Lowe, Christopher J., Shilpi Mahajan, Mike Reichelt, et al.. (2020). Enrichment of circulating tumor-derived extracellular vesicles from human plasma. Journal of Immunological Methods. 490. 112936–112936. 27 indexed citations
6.
Tan, Jingyi, Wenfeng Xu, Lei Lei, et al.. (2020). <p>Inhibition of Aurora Kinase A by Alisertib Reduces Cell Proliferation and Induces Apoptosis and Autophagy in HuH-6 Human Hepatoblastoma Cells</p>. OncoTargets and Therapy. Volume 13. 3953–3963. 9 indexed citations
8.
Tang, Qun, et al.. (2018). HIF1α deletion facilitates adipose stem cells to repair renal fibrosis in diabetic mice. In Vitro Cellular & Developmental Biology - Animal. 54(4). 272–286. 5 indexed citations
9.
Kuijper, Joseph L., Siv A. Hjorth, Mark Heipel, et al.. (2015). Cutting Edge: Identification of Neutrophil PGLYRP1 as a Ligand for TREM-1. The Journal of Immunology. 194(4). 1417–1421. 122 indexed citations
10.
Brandt, Cameron S., Myriam Baratin, Eugene C. Yi, et al.. (2009). The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. The Journal of Experimental Medicine. 206(7). 1495–1503. 526 indexed citations breakdown →
12.
Wolk, Kerstin, Harald S. Haugen, Wenfeng Xu, et al.. (2009). IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-γ are not. Journal of Molecular Medicine. 87(5). 523–536. 348 indexed citations
13.
Ling, Li, Ming Yang, Wenfeng Xu, et al.. (2008). Urinary fibronectin as a predictor of a residual tumour load after transurethral resection of bladder transitional cell carcinoma. British Journal of Urology. 102(5). 566–571. 10 indexed citations
14.
Erzurum, Serpil C., Sudipta Ghosh, Anna Janocha, et al.. (2007). Higher blood flow and circulating NO products offset high-altitude hypoxia among Tibetans. Proceedings of the National Academy of Sciences. 104(45). 17593–17598. 278 indexed citations
15.
Parrish-Novak, Julia, Wenfeng Xu, Ty Brender, et al.. (2002). Interleukins 19, 20, and 24 Signal through Two Distinct Receptor Complexes. Journal of Biological Chemistry. 277(49). 47517–47523. 231 indexed citations
16.
Gross, Jane A., Janet Johnston, Sherri Mudri, et al.. (2000). TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature. 404(6781). 995–999. 967 indexed citations breakdown →
17.
Xu, Wenfeng, et al.. (1998). Molecular Cloning of Human ABPL, an Actin-Binding Protein Homologue. Biochemical and Biophysical Research Communications. 251(3). 914–919. 62 indexed citations
18.
Xu, Wenfeng, et al.. (1998). A Novel Human Actin-Binding Protein Homologue That Binds to Platelet Glycoprotein Ib. Blood. 92(4). 1268–1276. 5 indexed citations
19.
Xu, Wenfeng, Henrik Andersen, Theodore E. Whitmore, et al.. (1998). Cloning and characterization of human protease-activated receptor 4. Proceedings of the National Academy of Sciences. 95(12). 6642–6646. 701 indexed citations breakdown →
20.
Xu, Wenfeng, et al.. (1998). A Novel Human Actin-Binding Protein Homologue That Binds to Platelet Glycoprotein Ib. Blood. 92(4). 1268–1276. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026